Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

NCT01431456 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Dabigatran
DRUG: Rivaroxaban
DRUG: Nadroparin

Sponsor

Martini Hospital Groningen